Biostar Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Biostar Pharmaceuticals generated cash of $4,912,665, which is less than the previous year. Cash used in financing activities reached the amount of $1,411,185 last year. Net change in cash is therefore $134,392.
Cash Flow
| 2010 | 12.84M | -8.53M | 37.53K |
|---|---|---|---|
| 2011 | 8.77M | -6.33M | 787.11K |
| 2012 | -3.58M | -17.28M | 5.54M |
| 2013 | 8.90M | -4.21M | -6.45M |
| 2014 | 3.31M | -8.87M | 6.95M |
| 2015 | 5.87M | -7.37M | -160.83K |
| 2016 | 4.91M | -6.37M | 1.41M |
BSPM Cash Flow Statement (2010 – 2016)
| 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 38.89K | 1.68M | 80.07K | 1.75M | 16.97M | 13.21M | 8.57M |
Operating activities | |||||||
Net income | -5.69M | -25.11M | 4.84M | 809.04K | -19.99M | 12.17M | 17.38M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 1.14M | 2.32M | 3.08M | 2.78M | 1.82M | 885.11K | 620.02K |
Stock-based compensation expense | 0 | 0 | 2.02M | 757.38K | 821.70K | 1.72M | 681.71K |
| Deferred income tax benefit | 0 | 0 | 2.02M | 757.38K | 821.70K | 1.72M | 681.71K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 8.66M | 5.44M | -7.44M | 4.20M | 6.62M | -5.33M | -8.05M |
Inventories | 55.14K | 420.58K | 152.45K | 43.46K | 535.58K | -609.96K | -11 |
Accounts payable | -1.08M | -602.95K | 573.10K | -1.44M | 3.19M | 0 | 0 |
Cash generated by operating activities | 4.91M | 5.87M | 3.31M | 8.90M | -3.58M | 8.77M | 12.84M |
Investing activities | |||||||
Purchases Of Investments | 0 | -804.18K | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -59.47K | -2.86M | -982.01K | -32.87K | -110.58K | -1.46M |
Acquisitions Net | -6.37M | -8.12M | -4.88M | -3.87M | -823.88K | -3.10M | -4.53M |
Cash generated by investing activities | -6.37M | -7.37M | -8.87M | -4.21M | -17.28M | -6.33M | -8.53M |
Financing activities | |||||||
Common Stock Issued | 1.68M | 0 | 3.86M | 0 | 0 | 0 | 37.53K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -278.31K | -160.83K | -162.71K | -6.45M | -792.19K | 0 | 0 |
Cash used in financing activities | 1.41M | -160.83K | 6.95M | -6.45M | 5.54M | 787.11K | 37.53K |
Net Change In Cash | 134.39K | -1.64M | 1.60M | -1.67M | -15.21M | 3.76M | 4.63M |
Cash at end of period | 173.29K | 38.89K | 1.68M | 80.07K | 1.75M | 16.97M | 13.21M |
| Data source | Data source | Data source |